Home › Amyotrophic Lateral Sclerosis › North Carolina › Durham
Amyotrophic Lateral Sclerosis clinical trials in Durham, NC
7 studies for Amyotrophic Lateral Sclerosis are looking for participants at sites in and around Durham (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
RecruitingPhase 2
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi away
ASSESS ALL ALS Study
RecruitingObservational studyHealthy volunteers welcome
- Duke University, Durham
PREVENT ALL ALS Study
RecruitingObservational studyHealthy volunteers welcome
- Duke University, Durham
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)
RecruitingObservational studyHealthy volunteers welcome
- University of North Carolina, Chapel Hill, Chapel Hill · 10 mi away
Intestinal Microbiome Transplant in ALS
RecruitingPhase 1/2
- Duke University Medical Center, Durham
Clinical Procedures to Support Research in ALS
RecruitingObservational study
- Duke University, Durham
Retinal Imaging in Neurodegenerative Disease
RecruitingObservational studyHealthy volunteers welcome
- Duke University Medical Center, Durham
About Amyotrophic Lateral Sclerosis
ALS stands for Amyotrophic Lateral Sclerosis, also called Lou Gehrig's disease. ALS affects the nervous system, causing muscle problems. Find out how.
More about Amyotrophic Lateral Sclerosis on MedlinePlus
Amyotrophic Lateral Sclerosis trials in other cities
- Boston, MA19 studies
- Philadelphia, PA14 studies
- Jacksonville, FL13 studies
- Baltimore, MD13 studies
- New York City, NY11 studies
- San Francisco, CA10 studies
- San Diego, CA10 studies
- Chicago, IL10 studies
- St. Louis, MO9 studies
- Dallas, TX8 studies
- Phoenix, AZ8 studies
- Atlanta, GA8 studies
Other studies in Durham
- Breast Cancer64 studies
- Cancer (all types)58 studies
- Non-Small Cell Lung Cancer39 studies
- Multiple Myeloma37 studies
- Acute Myeloid Leukemia33 studies
- Metastatic Cancer33 studies
- Prostate Cancer32 studies
- Lung Cancer32 studies
- Colorectal Cancer28 studies
- Ovarian Cancer27 studies
- Chronic Lymphocytic Leukemia27 studies
- Heart Failure26 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.